Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia

April 17, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH), a rare form of rickets.

Post navigation

← Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice Remarks from FDA Commissioner Scott Gottlieb, M.D. on Fiscal Year 2019 budget request for FDA →
Proudly powered by WordPress